23EHSPMRBTAGRMNTINSLN NOI to Enter into Negotiations for On-body Bolus Insulin Delivery Device

The Commonwealth of Massachusetts, through its Executive Office of Health and Human Services (EOHHS), which administers the state's Medicaid program (MassHealth) and the Health Safety Net (HSN), is issuing a Notice of Intent (NOI) to enter into negotiations with CeQur, the manufacturer of an on-body bolus insulin delivery device. The goal is to secure the largest possible rebate on claims for this device submitted through the Pharmacy Online Processing System (POPS), including for MassHealth members and HSN patients. EOHHS is posting this NOI to determine if there are any other qualified manufacturers interested in negotiating rebate agreements. Interested manufacturers must submit a response by June 14, 2023, expressing interest, providing information on FDA approvals, and details on the clinical benefits of their on-body bolus insulin delivery devices. EOHHS does not guarantee any particular volume of MassHealth member utilization of the on-body bolus insulin delivery devices during the term of the rebate agreement, but reserves the option to include MassHealth member utilization through Managed Care Entities in the negotiated agreement. EOHHS will review all responses received and determine whether to proceed with negotiations with the known manufacturer, one or more other manufacturers, or withdraw the notice entirely.

The NOI is specific to Suffolk County, Massachusetts, and EOHHS has not indicated any set-aside designations or restrictions on the types of organizations that can respond. The agency has not listed any incumbent vendors or current contractors, nor has it provided any information on existing infrastructure or technology that requires integration. The agency has also not disclosed any possible award values or budget ranges.